Compare ETFs
Up to five funds side by side — fees, size, yields, performance, risk, top holdings and sector mix, with a normalized total-return chart.
| Metric |  LFSC F/M Emerald Life Sciences… |
|---|---|
| Price | 47.58 -0.93% |
| Issuer | F/m |
| AUM | $74.7M |
| Expense Ratio | 0.54% |
| Yield (TTM) | — |
| Inception | Oct 21, 2024 |
| Holdings | — |
| Avg Volume | 4.11K |
| YTD | +29.98% |
| 1Y total | +71.89% |
| 3Y total (ann.) | — |
| 5Y total (ann.) | — |
| Volatility 1Y | 27.39% |
| Sharpe 1Y | 2.74 |
| Max drawdown 1Y | -16.24% |
| Beta vs S&P 500 (3Y) | 1.02 |
| Top 10 holdings | TVTX 8.25% SYRE 7.73% CORT 6.88% COGT 6.52% LIVN 6.24% MIRM 4.08% BLLN 3.94% GH 3.89% CYTK 3.65% UTHR 3.19% |
| Sector mix |
Total Return — normalized
Dividend-adjusted daily closes over the last 12 months, normalized to 0% at the range start.
Market data delayed approximately 15–20 minutes unless otherwise indicated. Comparison presents measurable characteristics only — it is not advice about which fund suits anyone.